Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-02 Purchase |
2021-12-06 5:31 pm |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
34,326 | $12.82 | $440,059 | 14,186,922 (Indirect) |
View |
| 2021-11-30 Purchase |
2021-12-02 5:24 pm |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
97,151 | $12.24 | $1,189,199 | 14,186,126 (Indirect) |
View |
| 2021-11-26 Purchase |
2021-11-30 5:26 pm |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
68,523 | $11.64 | $797,426 | 14,183,872 (Indirect) |
View |
| 2021-06-02 Purchase |
2021-06-04 5:01 pm |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
600,000 | $20 | $12,000,000 | 16,114,101 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-21 Other |
2022-03-23 4:36 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
1,839,265 | $0 | 10,605,119 (Indirect) |
View |
| 2021-01-29 Option Award |
2021-06-04 5:01 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
1,931,818 | $11 | 16,114,101 (Indirect) |
View |
| 2021-06-02 Conversion |
2021-06-04 5:01 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
1,931,818 | $0 | 16,114,101 (Indirect) |
View |
Ownership |
2021-05-27 8:20 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
0 | $0 | 17,323,892 (Indirect) |
View |